サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/01 | 1,069 | 1,103 | 1,063 | 1,097 | +28 | +2.6% | 637,100 |
2022/07/29 | 1,030 | 1,069 | 1,026 | 1,069 | +44 | +4.3% | 890,900 |
2022/07/28 | 1,058 | 1,066 | 1,022 | 1,025 | -26 | -2.5% | 1,434,500 |
2022/07/27 | 1,050 | 1,078 | 1,041 | 1,051 | -11 | -1% | 943,400 |
2022/07/26 | 1,080 | 1,110 | 1,033 | 1,062 | -23 | -2.1% | 1,672,100 |
2022/07/25 | 1,132 | 1,187 | 1,075 | 1,085 | -227 | -17.3% | 4,868,400 |
2022/07/22 | 1,297 | 1,331 | 1,268 | 1,312 | -3 | -0.2% | 795,200 |
2022/07/21 | 1,300 | 1,318 | 1,246 | 1,315 | -12 | -0.9% | 1,230,000 |
2022/07/20 | 1,387 | 1,387 | 1,295 | 1,327 | -34 | -2.5% | 1,810,300 |
2022/07/19 | 1,249 | 1,374 | 1,233 | 1,361 | +125 | +10.1% | 2,698,800 |
2022/07/15 | 1,305 | 1,323 | 1,203 | 1,236 | -68 | -5.2% | 2,397,000 |
2022/07/14 | 1,211 | 1,398 | 1,167 | 1,304 | +123 | +10.4% | 6,355,600 |
2022/07/13 | 1,105 | 1,220 | 1,100 | 1,181 | +78 | +7.1% | 2,464,300 |
2022/07/12 | 1,041 | 1,118 | 1,036 | 1,103 | +63 | +6.1% | 1,522,900 |
2022/07/11 | 1,033 | 1,040 | 1,028 | 1,040 | +7 | +0.7% | 900,500 |
2022/07/08 | 1,027 | 1,034 | 1,020 | 1,033 | +8 | +0.8% | 740,800 |
2022/07/07 | 1,028 | 1,031 | 1,008 | 1,025 | -2 | -0.2% | 883,700 |
2022/07/06 | 1,030 | 1,035 | 1,023 | 1,027 | -2 | -0.2% | 467,300 |
2022/07/05 | 1,031 | 1,033 | 1,020 | 1,029 | -2 | -0.2% | 183,000 |
2022/07/04 | 1,035 | 1,039 | 1,007 | 1,031 | -1 | -0.1% | 524,300 |
2022/07/01 | 1,066 | 1,066 | 1,027 | 1,032 | -27 | -2.5% | 363,400 |
2022/06/30 | 1,111 | 1,117 | 1,056 | 1,059 | -40 | -3.6% | 388,300 |
2022/06/29 | 1,130 | 1,137 | 1,099 | 1,099 | -39 | -3.4% | 373,800 |
2022/06/28 | 1,135 | 1,169 | 1,127 | 1,138 | -4 | -0.4% | 456,600 |
2022/06/27 | 1,160 | 1,166 | 1,134 | 1,142 | -12 | -1% | 336,400 |
2022/06/24 | 1,101 | 1,159 | 1,098 | 1,154 | +64 | +5.9% | 805,300 |
2022/06/23 | 1,087 | 1,099 | 1,079 | 1,090 | +3 | +0.3% | 217,800 |
2022/06/22 | 1,077 | 1,093 | 1,063 | 1,087 | +3 | +0.3% | 250,600 |
2022/06/21 | 1,036 | 1,092 | 1,027 | 1,084 | +56 | +5.4% | 368,300 |
2022/06/20 | 1,046 | 1,057 | 1,006 | 1,028 | -20 | -1.9% | 349,900 |
2022/06/17 | 1,069 | 1,095 | 1,038 | 1,048 | -48 | -4.4% | 616,900 |
2022/06/16 | 1,067 | 1,108 | 1,038 | 1,096 | +54 | +5.2% | 948,800 |
2022/06/15 | 1,050 | 1,078 | 1,020 | 1,042 | +22 | +2.2% | 802,000 |
2022/06/14 | 1,050 | 1,051 | 994 | 1,020 | -41 | -3.9% | 900,100 |
2022/06/13 | 1,085 | 1,087 | 1,061 | 1,061 | -35 | -3.2% | 310,900 |
2022/06/10 | 1,114 | 1,118 | 1,093 | 1,096 | -24 | -2.1% | 328,600 |
2022/06/09 | 1,115 | 1,126 | 1,102 | 1,120 | +5 | +0.4% | 305,700 |
2022/06/08 | 1,108 | 1,119 | 1,085 | 1,115 | +28 | +2.6% | 362,400 |
2022/06/07 | 1,111 | 1,113 | 1,086 | 1,087 | -24 | -2.2% | 204,200 |
2022/06/06 | 1,082 | 1,112 | 1,078 | 1,111 | +27 | +2.5% | 297,100 |
2022/06/03 | 1,095 | 1,098 | 1,070 | 1,084 | +6 | +0.6% | 233,000 |
2022/06/02 | 1,087 | 1,087 | 1,058 | 1,078 | -9 | -0.8% | 227,200 |
2022/06/01 | 1,106 | 1,116 | 1,082 | 1,087 | -19 | -1.7% | 311,600 |
2022/05/31 | 1,103 | 1,125 | 1,088 | 1,106 | -4 | -0.4% | 373,300 |
2022/05/30 | 1,086 | 1,111 | 1,069 | 1,110 | +39 | +3.6% | 399,900 |
2022/05/27 | 1,051 | 1,076 | 1,041 | 1,071 | +24 | +2.3% | 262,800 |
2022/05/26 | 1,050 | 1,059 | 1,036 | 1,047 | +3 | +0.3% | 284,500 |
2022/05/25 | 1,106 | 1,106 | 1,043 | 1,044 | -60 | -5.4% | 567,700 |
2022/05/24 | 1,126 | 1,132 | 1,096 | 1,104 | -41 | -3.6% | 262,100 |
2022/05/23 | 1,150 | 1,152 | 1,120 | 1,145 | ±0 | ±0% | 329,600 |
751~
800
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム